Google Alert - in

	in As-it-happens update ⋅ 8 May 2020
	NEWS
	This is what COVID-19 did to start-ups in China World Economic Forum (blog) A 6-month drought in VC deals will wipe out a large portion of startups. Survivors of the crisis will emerge as potentially massive winners at the end. As ... Flag as irrelevant
	Coronavirus live updates: Australia plans reopening in 3 stages; Germany reports over 1200 cases CNBC A reignition in U.S.-China trade tensions would be the "the last thing" anyone needs when the world is already reeling from the economic impact of the ... Flag as irrelevant
	Majority of small publishers fear closure in wake of coronavirus The Guardian Majority of small publishers fear closure in wake of coronavirus. Survey shows 60% expect the impact of the pandemic may put them out of business, ... Flag as irrelevant
	NFL Releases 2020 Schedule Even as Start Remains in Doubt The New York Times The league had already canceled the international games in London and Mexico City, moving them back to the United States. But it did not, for instance, ... Flag as irrelevant
	Coronavirus: 'Will we have to stay in isolation for a year?' BBC News In her previous life, travelling internationally as a psychologist and leadership coach, the plants would never have survived, she says. She and her ... Flag as irrelevant
	The Belt and Road in Sri Lanka: Beyond the Debt Trap Discussion The Diplomat In this Jan. 2, 2018, file photo, a Chinese construction worker stands on land that was reclaimed from the Indian Ocean for the Colombo Port City project, ... Flag as irrelevant
	Vista Equity Partners to invest $1.5B in India's Reliance Jio Platforms TechCrunch Vista, which began investing in software firms 20 years ago and has cut checks to more than three dozen companies, said it would explore ways to ... Flag as irrelevant
	WEB
	Protect your accounts with smarter ways to sign in on World Passwordless Day Microsoft Given the increase in remote work, the need to go passwordless and use Multifactor Authentication (MFA) is even more significant. In honor of World ... Flag as irrelevant
	Gilead Announces Approval of Veklury® (remdesivir) in Japan for Patients With Severe COVID-19 Gilead Sciences, Inc. In the United States , remdesivir is an investigational drug that has not been approved by the FDA for any use, and the safety and efficacy of remdesivir ... Flag as irrelevant

You have received this email because you have subscribed to Google Alerts. Unsubscribe

Receive this alert as RSS feed

Send Feedback

ShareThis